| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/05/2011 | CA2439120C Erodible polymers for injection |
| 07/05/2011 | CA2439099C Anti-platelet and anti-thrombotic agents |
| 07/05/2011 | CA2433368C Adsorbent for oral administration |
| 07/05/2011 | CA2421042C The use of tiagabine for treatment of diabetic neuropathy and migraine |
| 07/05/2011 | CA2405767C Pharmaceutical formulations for dry powder inhalers |
| 07/05/2011 | CA2389239C Cosmetic gel bead manufacturing method and apparatus |
| 07/05/2011 | CA2288540C Defined serumfree medical solution for ophthalmology |
| 06/30/2011 | WO2011079302A2 Swallowable drug delivery device and methods of drug delivery |
| 06/30/2011 | WO2011079279A2 Nanoconjugates and nanoconjugate formulations |
| 06/30/2011 | WO2011079260A2 Stabilized virus like particles having enhanced mucosal immunogenicity |
| 06/30/2011 | WO2011079239A2 Combination tablet with chewable outer layer |
| 06/30/2011 | WO2011079234A2 Highly permeating terbinafine formulation |
| 06/30/2011 | WO2011079232A1 Sustained release delivery devices |
| 06/30/2011 | WO2011079209A1 Polymerizable lactamic copolymers suitable for the formation of coatings on microencapsulated particles |
| 06/30/2011 | WO2011079156A1 Extended release formulation and methods of treating adrenergic dysregulation |
| 06/30/2011 | WO2011079127A1 Abt-263 capsule |
| 06/30/2011 | WO2011079119A1 Formulation comprising 1 h - quinazoline - 2, 4 - dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof |
| 06/30/2011 | WO2011078993A1 Functionally-coated multilayer tablets |
| 06/30/2011 | WO2011078990A1 Hydrogels comprising hyaluronan and at least one t cell induction agent |
| 06/30/2011 | WO2011078983A1 Treatment for inflammatory bowel disease |
| 06/30/2011 | WO2011078832A1 Effervescent formulations comprising cefixime |
| 06/30/2011 | WO2011078831A1 Improved pharmaceutical compositions comprising cefdinir |
| 06/30/2011 | WO2011078830A1 Rapidly dispersing effervescent formulation |
| 06/30/2011 | WO2011078829A1 Rapidly dispersing pharmaceutical formulation with cefdinir |
| 06/30/2011 | WO2011078828A1 Pharmaceutical composition with high purity |
| 06/30/2011 | WO2011078827A1 The production method for effervescent tablet with cefdinir |
| 06/30/2011 | WO2011078824A1 Dry powder formulation containing tiotropium for inhalation |
| 06/30/2011 | WO2011078823A1 Compositions containing salmeterol, fluticasone and cromoglicic acid |
| 06/30/2011 | WO2011078822A1 Pharmaceutical compositions comprising cefdinir as an active agent |
| 06/30/2011 | WO2011078821A1 Effervescent tablet and granule formulation comprising cefixime |
| 06/30/2011 | WO2011078818A1 Dry powder combination of tiotropium, a corticosteroid and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078817A1 Combination of tiotropium, mometasone and a cromoglicic acid derivative in dry powder form |
| 06/30/2011 | WO2011078816A1 Dry powder combination of tiotropium, formoterol and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078815A1 Dry powder combination of tiotropium, budesonide and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078712A1 Combination composition useful for treating cardiovascular diseases |
| 06/30/2011 | WO2011078700A1 Topical oral gel formulations for dental use |
| 06/30/2011 | WO2011078457A2 Ph-sensitive block copolymer forming polyionic complex micelle, and drug or protein delivery vehicle using same |
| 06/30/2011 | WO2011078394A2 Sustained-release formulation |
| 06/30/2011 | WO2011078383A1 Low-viscosity liquid-crystal compound |
| 06/30/2011 | WO2011078367A1 Emulsion composition |
| 06/30/2011 | WO2011077843A1 Atrovastatin-containing coated preparation |
| 06/30/2011 | WO2011077759A1 Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) - |
| 06/30/2011 | WO2011077674A1 Hydrogel particles |
| 06/30/2011 | WO2011077451A2 Controlled release pharmaceutical composition |
| 06/30/2011 | WO2011077406A2 Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan |
| 06/30/2011 | WO2011077402A2 Amphiphilic polymer functionalised by methionine |
| 06/30/2011 | WO2011077347A2 Active ingredient delivery system |
| 06/30/2011 | WO2011077239A2 Slow release pharmaceutical compositions of iloperidone |
| 06/30/2011 | WO2011077169A2 Pharmaceutical preparation |
| 06/30/2011 | WO2011076879A1 Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine |
| 06/30/2011 | WO2011076843A2 Combination therapy for copd |
| 06/30/2011 | WO2011076842A2 Aerosol formulation for copd |
| 06/30/2011 | WO2011076841A2 Combination therapy for copd |
| 06/30/2011 | WO2011076840A2 Aerosol formulation for copd |
| 06/30/2011 | WO2011076807A2 Lipids, lipid compositions, and methods of using them |
| 06/30/2011 | WO2011076749A2 Solid pharmaceutical dosage form |
| 06/30/2011 | WO2011076743A1 Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt |
| 06/30/2011 | WO2011076738A1 Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt |
| 06/30/2011 | WO2011076721A1 Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
| 06/30/2011 | WO2011076702A1 Pharmaceutical compositions comprising igf-1 proteins, a buffering and a tonicity agent |
| 06/30/2011 | WO2011076621A2 Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| 06/30/2011 | WO2011076412A1 Oral form of administration comprising entecavir |
| 06/30/2011 | WO2011076411A1 Orodispersible tablet contained compacted sildenafil base |
| 06/30/2011 | WO2011076401A1 Substantially water-free pharmaceutical compositions containing acetylsalicylic acid |
| 06/30/2011 | WO2011076368A2 Topical ophthalmic peptide formulation |
| 06/30/2011 | WO2011076216A2 Wound care products |
| 06/30/2011 | WO2011076209A2 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue |
| 06/30/2011 | WO2011076208A2 Calcipotriol monohydrate nanocrystals |
| 06/30/2011 | WO2011076207A2 Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants |
| 06/30/2011 | WO2011076206A1 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture |
| 06/30/2011 | WO2011076019A1 Mixed compound medicament of natural medicine component and no donator and use thereof |
| 06/30/2011 | WO2011075935A1 Diphenylethene derivatives and uses thereof |
| 06/30/2011 | WO2011075912A1 Pharmaceutical composition for treating parkinson's disease and preparation method thereof |
| 06/30/2011 | WO2011075848A1 Epsilon-poly-lysine capsules |
| 06/30/2011 | WO2011056741A3 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| 06/30/2011 | WO2011056240A3 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 06/30/2011 | WO2011056115A8 Lipid layer forming composition for administration onto a surface of a living organism |
| 06/30/2011 | WO2011048388A3 Oral pharmaceutical and nutraceutical compositions |
| 06/30/2011 | WO2011039637A3 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| 06/30/2011 | WO2011030351A3 Taste - masked pharmaceutical compositions |
| 06/30/2011 | WO2011022467A3 Controlled-release formulations of anabaseine compounds and uses thereof |
| 06/30/2011 | WO2011022371A8 Gel product |
| 06/30/2011 | WO2011012322A3 Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms |
| 06/30/2011 | WO2010150982A3 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same |
| 06/30/2011 | WO2010138194A3 Immunomodulatory agent-polymeric compounds |
| 06/30/2011 | WO2010117287A3 A virus-like particle vector for delivery of pharmaceutical agents, a process for the manufacture thereof, its uses and a pharmaceutical composition. |
| 06/30/2011 | WO2010094731A3 Pharmaceutical composition for inhalation |
| 06/30/2011 | WO2010070023A3 Pharmaceutical orally deliverable formulations |
| 06/30/2011 | US20110160845 Drug delivery system and method of manufacturing thereof |
| 06/30/2011 | US20110160708 Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles |
| 06/30/2011 | US20110160642 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases |
| 06/30/2011 | US20110160634 Canker sore patch |
| 06/30/2011 | US20110160245 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 06/30/2011 | US20110160224 Aripiprazole complex formulation and method |
| 06/30/2011 | US20110159169 Drug releasing coatings for medical devices |
| 06/30/2011 | US20110159103 Novel Preparation of an Enteric Release System |
| 06/30/2011 | US20110159102 Apparatus and Method for Continuous Production of Spherical Powder Agglomerates |
| 06/30/2011 | US20110159101 Silyl ether-modified hydrophilic polymers and uses for medical articles |
| 06/30/2011 | US20110159100 Formulations and methods for the controlled release of active drug substances |
| 06/30/2011 | US20110159099 Bone-filling type agent for inducing cartilage regeneration |